IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Reader Login
Users Online : 7888 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Ľ   My Preferences 
  Ľ   Manuscript submission


Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2021| May-June  | Volume 53 | Issue 3  
    Online since June 22, 2021

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
Retrospective pharmacovigilance analysis of nonsteroidal anti-inflammatory drugs-induced chronic kidney disease
Vardhipathi Sravana Swathi, Shrishti Saroha, Jai Prakash, Shashi Bhushan
May-June 2021, 53(3):192-197
DOI:10.4103/ijp.IJP_704_20  PMID:34169903
  4,562 286 -
Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak
Vidya Mahalmani, J Kumaravel, Manav Jain, Ajay Prakash, Bikash Medhi
May-June 2021, 53(3):187-191
DOI:10.4103/ijp.ijp_430_21  PMID:34169902
  4,024 217 -
Nephroprotective effects of ethanolic root extract of Azima tetracantha lam in adenine-induced chronic kidney failure in Wistar rats
Ruckmani Arunachalam, Venu Gopala Rao Konda, Madhavi Eerike, Arun Kumar Radhakrishnan, Sobita Devi
May-June 2021, 53(3):198-206
DOI:10.4103/ijp.IJP_552_19  PMID:34169904
  3,649 227 -
Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review
Ajay Prakash, Sukhmeet Kaur, Charanjeet Kaur, Praisy K Prabha, Anusuya Bhatacharya, Phulen Sarma, Bikash Medhi
May-June 2021, 53(3):236-243
DOI:10.4103/ijp.ijp_382_21  PMID:34169911
  2,897 152 -
Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study
Anitha Gunalan, Dhandapani Sarumathi, Apurba Sankar Sastry, Venkateswaran Ramanathan, Sathish Rajaa, Sujatha Sistla
May-June 2021, 53(3):207-212
DOI:10.4103/ijp.ijp_1013_20  PMID:34169905
  2,471 119 -
The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study
Jithin Chacko, Shankar Dhandapani, Vidhya Jahagiridhar, Krishnan Swaminathan
May-June 2021, 53(3):229-233
DOI:10.4103/ijp.IJP_669_18  PMID:34169909
  2,190 95 -
Copper-lowering agents as an adjuvant in chemotherapy
Pramod Kadu, Bhakti Sawant, Pravin Popatrao Kale, Kedar Prabhavalkar
May-June 2021, 53(3):221-225
DOI:10.4103/ijp.IJP_68_20  PMID:34169907
  2,119 71 -
Evaluation of vanillin as a probe drug for aldehyde oxidase and phenotyping for its activity in a Western Indian Cohort
Sandhya Subash, Nithya J Gogtay, Krishna R Iyer, Prajakta Gandhe, Ritu Budania, Urmila M Thatte
May-June 2021, 53(3):213-220
DOI:10.4103/ijp.IJP_463_18  PMID:34169906
  2,094 93 -
Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors
Erkan Cure, Adem Kucuk, Medine Cumhur Cure
May-June 2021, 53(3):226-228
DOI:10.4103/ijp.IJP_615_20  PMID:34169908
  2,109 71 -
A case report on azathioprine-induced euprolactinemic galactorrhea
Deepa Chaudhary, Ratinder Jhaj
May-June 2021, 53(3):234-235
DOI:10.4103/ijp.ijp_159_18  PMID:34169910
  1,922 69 -
Written informed consent to virtual e-consent in clinical research: Changing necessity during COVID times
Apoorva Mathur
May-June 2021, 53(3):248-249
DOI:10.4103/ijp.ijp_331_21  PMID:34169914
  1,618 82 -
Attitude toward COVID-19 vaccination: A cross-sectional study on healthcare professionals
Suresh Velumani, Patel Arpita, Ramachandran Balaraman
May-June 2021, 53(3):250-251
DOI:10.4103/ijp.ijp_173_21  PMID:34169915
  1,310 100 -
Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19
Yethindra Vityala, Tugolbai Tagaev, Sagynali Mamatov, Ziiabidin Aidarov, Panchadcharam Harinath
May-June 2021, 53(3):246-247
DOI:10.4103/ijp.IJP_33_21  PMID:34169913
  1,203 58 -
Candidiasis in patients treated with interleukin-17 inhibitors
Nerea BŠez-Gutierrez, Hťctor RodrŪguez-Ramallo
May-June 2021, 53(3):244-245
DOI:10.4103/ijp.ijp_1178_20  PMID:34169912
  332 27 -
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow